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Pennington and Tidball: Continuing the Fight

Researchers work across disciplines
to end COVID-19 pandemic
By Erin Pennington and Jennifer Tidball
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When the world paused during the COVID-19 pandemic, many Kansas
State University researchers did the opposite.
K-State researchers increased their efforts or pivoted focus to join the
battle against the novel coronavirus. By February 2021 — nearly a year
after the World Health Organization declared the COVID-19 pandemic
— K-State had more than $35 million in coronavirus-related grant
proposals, more than $12 million in contracts for COVID-19 research
and several new technologies licensed to corporate partners to combat
the disease.
Research across the university has ranged from treatment and vaccine
development to understanding the pandemic’s effects on early learners.
Read more about the variety of K-State projects during the pandemic.

Candidate compound
A series of protease inhibitors developed, patented and licensed by
K-State continues to help the fight against coronaviruses, including
SARS-CoV-2, the virus that causes COVID-19. Cocrystal Pharma
Inc., a clinical-stage biotechnology company, has selected the protease
inhibitors as a preclinical lead compound for further development.
Kyeong-Ok “KC” Chang and Yunjeong Kim, virologists in the K-State
College of Veterinary Medicine, developed the protease inhibitors in
collaboration with William Groutas at Wichita State University and
Stanley Perlman at the University of Iowa. K-State Innovation Partners
licensed the protease inhibitors, which could lead to a possible COVID19 drug or treatment.
“Further studies are required to reveal the therapeutic potency of our
protease inhibitor compared to other approved drugs,” Kim said. “Drugs
targeting different virus proteins are often combined to maximize their
efficacy, so it is always nice to have a repertoire of drugs that work in
different ways.”
Preclinical animal studies of these K-State coronavirus compounds
published in the prestigious medical journal Science Translational
Medicine showed efficacy against Middle East respiratory syndrome, or
MERS, a related deadly human coronavirus infection, in a mouse model.
Further testing allowed Cocrystal to identify this promising candidate
for preclinical lead development for COVID-19. According to the
company, the compound potentially could be delivered through injection

Virologists Yunjeong Kim, left, and Kyeong-Ok “KC” Chang have developed a series of
protease inhibitors.
or inhalation and could be used as both a therapeutic and prophylactic, which protects uninfected
individuals who may become exposed.
With the selection of this candidate, Cocrystal will initiate studies to evaluate potential toxicity risks
and conduct safety pharmacology studies before the phase 1 clinical trial.
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Developing the research space
K-State recently received a $1.2 million University
SARS-CoV-2/COVID Research and Diagnostic Capacity
Support Grant from the Kansas Department of
Commerce as part of the Coronavirus Aid, Relief and
Economic Security Act — known as the CARES Act —
distribution. These funds will launch a Biotechnology
Development Module, or BDM, at the K-State
Biosecurity Research Institute, or BRI.
The National Bio and Agro-Defense Facility, or NBAF
— nearing completion adjacent to K-State’s Manhattan
campus — will house a BDM for companies to increase
manufacturing for a limited number of select agent
countermeasures. The K-State BDM at the BRI will be a
complementary pilot-scale facility for research that does
not focus only on NBAF-priority diseases.

The K-State BDM will allow researchers and corporate
partners to develop diagnostic, therapeutic and preventive
countermeasures for a broad range of emerging zoonotic
diseases, including SARS-CoV-2 and African swine
fever virus. The facility will be located in unique close
proximity to containment and non-containment animal
facilities as well as the Kansas State Veterinary Diagnostic
Laboratory.
“K-State’s strengths in addressing threats to plant, animal
and human health are more important than ever before,”
said Beth Montelone, interim vice president for research.
“This grant will enable K-State to continue to grow its
vaccine and other countermeasure development strategy
to address new and emerging diseases.”

A Biotechnology Development Module at the Biosecurity
Research Institute will allow research on emerging
pathogens.

Environmental stability
K-State researchers are helping understand how long SARS-CoV-2 can
survive on different types of surfaces and in various temperatures.
A Center of Excellence for Emerging and Zoonotic Animal Diseases,
or CEEZAD, team recently completed a BRI study on the topic. The
researchers, also from the College of Veterinary Medicine, included
Taeyong Kwon, doctoral student in pathobiology; Natasha Gaudreault,
research assistant professor of diagnostic medicine and pathobiology;
and Jürgen A. Richt, Regents distinguished professor and CEEZAD
director.
The study resulted in several important insights into SARS-CoV-2
survival, including:
» The virus survived the longest — 21 days after contamination — on
surfaces under winter conditions.
» In spring and fall conditions, the virus survived up to seven days.
» No infectious virus was found three days after contamination under
summer conditions.
» Under indoor conditions, infectious virus was recovered from
cloth up to one day after contamination; for up to three days from
concrete, polypropylene, stainless steel and galvanized steel; and for
up to four days from nitrile gloves, Tyvek, N95 masks, Styrofoam,
cardboard, rubber and glass.

A K-State study focuses on how long the SARS-CoV-2
virus survives in different climates and on different
surfaces, such as gloves, masks, glass and cardboard.
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“These findings clarify a major concern among scientists, and also
among members of the general public, namely the ability of the SARSCoV-2 to survive on various surfaces under varying climatic conditions,”
Richt said. “It shows that the virus’s ability to remain a threat is greatest
in winter and less in summer. But it also shows that even in indoor
conditions, SARS-CoV-2 remains viable for several days depending on
the surface.”
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Understanding quarantine

Analyzing contact tracing

Kyle Goerl, medical director of K-State’s Lafene Health
Center, is part of a collaborative team providing researchbased guidance during the COVID-19 pandemic. The
Centers for Disease Control and Prevention has used
the team’s research to update and shorten quarantine
guidance.

K-State engineers are investigating some of the hidden
mechanisms behind the spread of COVID-19.
In their latest work, the researchers in the Carl R. Ice
College of Engineering are modeling the spread of
COVID-19 and evaluating the effectiveness of disease
mitigation measures. Specifically, they have studied the
benefits and costs of contact tracing and how effective it
is in containing the spread of COVID-19.

Goerl is a co-author of a quarantine-related publication
that recently appeared in the CDC Morbidity and
Mortality Weekly Report and involved multiple
organizations and universities.

“Contact tracing plays a vital role as a critical mitigation
strategy for COVID-19,” said Sifat Afroj Moon, doctoral
student in electrical and computer engineering. “Our
investigation indicates that a sufficient amount of contact
tracing can reduce the impact of COVID-19 spreading in
the reopening process of a location.”

The publication describes a sample of COVID-19exposed collegiate athletes in 17 states from June to
October 2020. Twenty-five percent of the athletes tested
positive during quarantine and the positive test occurred
an average of 3.8 days after quarantine started. As
quarantine progressed, the probability of testing positive
dropped from 27% after day five to less than 5% after
day 10.
“These findings show that after 10 days of quarantine,
the risk of COVID-19 is relatively low,” said Goerl, also
a team physician for Kansas State University Athletics.
“This helps to support a quarantine period that is shorter
than 14 days. If the quarantine period is shortened, it is
more likely that people will follow important quarantine
measures.”

Moon works with Caterina Scoglio, the LeRoy and
Aileen Paslay professor and Steve Hsu Keystone research
scholar in the Mike Wiegers Department of Electrical
and Computer Engineering. They recently published their
findings on contact tracing in Nature Scientific Reports.
The researchers are continuing their modeling research
and also are studying and simulating the effectiveness of
multiple COVID-19 vaccination strategies.
Kyle Goerl, K-State medical director, is helping provide
research-based quarantine guidance.

K-State COVID-19 research

Effect on early learners

$35 million+

Adelaide Klutse, master’s student in applied family
science in the College of Health and Human Sciences,
is studying how teachers are facilitating the socialemotional development of children ages 0 through 5
during the COVID-19 pandemic.

In grant proposals.

$12 million+

In grant awards.

Her research is providing knowledge on the availability
and kinds of support targeted at empowering early
educators during the pandemic.

3

Technology option or license agreements.

Klutse is working with adviser Bradford Wiles, associate
professor of applied human sciences, to understand
how teachers facilitate social-emotional development in
children when close contact and touch are major risks
for disease transmission. She is researching how teachers’
perceived levels of stress affect their classroom qualities
and their abilities to help children with social-emotional
development.

20+

Studies at the Biosecurity Research
Institute conducted during 2020 and 2021.

25+

Researchers and staff involved in
COVID-19 research at the Biosecurity
Research Institute.

According to Klutse, this study is significant because
current research does not include early childhood
education teachers who are facilitating development in
the early years.
“Research suggests children spend a considerable number
of hours with their teachers and these teachers’ abilities
to facilitate socioemotional development in children
goes a long way toward influencing family outcomes in
current and future families,” Klutse said.

By the numbers

Seek more
Read more and find K-State research
publications related to COVID-19.
Adelaide Klutse, master’s student in applied family
science, is studying how children are adapting during
the pandemic.
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